A Multi-center, Open-label Study in Elderly Healthy Volunteers and Elderly Patients With Major Depressive Disorder to Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs ABP 688 (Primary)
- Indications Major depressive disorder
- Focus Pharmacokinetics
Most Recent Events
- 08 Dec 2020 Biomarkers information updated
- 10 Feb 2012 New trial record